SIGA Technologies, Inc. (SIGA)
USD 6.4
(2.48%)
USD 6.4
(2.48%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -148.68 Million USD | -51.31% |
| 2022 | -98.26 Million USD | 4.29% |
| 2021 | -102.67 Million USD | 12.58% |
| 2020 | -117.44 Million USD | -871.85% |
| 2019 | 15.21 Million USD | 160.61% |
| 2018 | -25.1 Million USD | -149.04% |
| 2017 | 51.19 Million USD | 35.25% |
| 2016 | 37.85 Million USD | 133.58% |
| 2015 | -112.71 Million USD | -15.34% |
| 2014 | -97.72 Million USD | -11.88% |
| 2013 | -87.35 Million USD | -222.24% |
| 2012 | -27.1 Million USD | 44.97% |
| 2011 | -49.25 Million USD | -677.9% |
| 2010 | -6.33 Million USD | 56.32% |
| 2009 | -14.49 Million USD | -524.43% |
| 2008 | -2.32 Million USD | 66.02% |
| 2007 | -6.83 Million USD | 34.99% |
| 2006 | -10.5 Million USD | -574.42% |
| 2005 | -1.55 Million USD | 22.89% |
| 2004 | -2.02 Million USD | -40.27% |
| 2003 | -1.44 Million USD | 29.99% |
| 2002 | -2.05 Million USD | 30.38% |
| 2001 | -2.95 Million USD | -532.43% |
| 2000 | -467.39 Thousand USD | 53.26% |
| 1999 | -1 Million USD | 74.36% |
| 1998 | -3.9 Million USD | 63.55% |
| 1997 | -10.7 Million USD | 0.0% |
| 1996 | - USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -142.56 Million USD | 4.11% |
| 2024 Q2 | -105.32 Million USD | 26.12% |
| 2023 FY | -148.68 Million USD | -51.31% |
| 2023 Q1 | -115.14 Million USD | -17.18% |
| 2023 Q2 | -75.66 Million USD | 34.28% |
| 2023 Q3 | -70.55 Million USD | 6.75% |
| 2023 Q4 | -148.68 Million USD | -110.72% |
| 2022 Q1 | -152.77 Million USD | -48.8% |
| 2022 Q2 | -114.02 Million USD | 25.36% |
| 2022 Q3 | -109.23 Million USD | 4.2% |
| 2022 Q4 | -98.26 Million USD | 10.04% |
| 2022 FY | -98.26 Million USD | 4.29% |
| 2021 Q4 | -102.67 Million USD | -11.21% |
| 2021 FY | -102.67 Million USD | 12.58% |
| 2021 Q3 | -92.32 Million USD | 5.84% |
| 2021 Q1 | -106.13 Million USD | 9.63% |
| 2021 Q2 | -98.05 Million USD | 7.61% |
| 2020 Q2 | -52.63 Million USD | 31.6% |
| 2020 Q4 | -117.44 Million USD | -50.14% |
| 2020 Q3 | -78.22 Million USD | -48.62% |
| 2020 FY | -117.44 Million USD | -871.85% |
| 2020 Q1 | -76.95 Million USD | -605.74% |
| 2019 Q1 | -25.42 Million USD | -1.29% |
| 2019 Q3 | 1.22 Million USD | 105.56% |
| 2019 Q2 | -22.08 Million USD | 13.17% |
| 2019 FY | 15.21 Million USD | 160.61% |
| 2019 Q4 | 15.21 Million USD | 1138.53% |
| 2018 Q2 | 62.69 Million USD | 7.69% |
| 2018 Q4 | -25.1 Million USD | 15.1% |
| 2018 Q1 | 58.22 Million USD | 13.74% |
| 2018 FY | -25.1 Million USD | -149.04% |
| 2018 Q3 | -29.57 Million USD | -147.16% |
| 2017 Q3 | 44.11 Million USD | 16.36% |
| 2017 FY | 51.19 Million USD | 35.25% |
| 2017 Q1 | 37.55 Million USD | -0.77% |
| 2017 Q2 | 37.91 Million USD | 0.96% |
| 2017 Q4 | 51.19 Million USD | 16.03% |
| 2016 Q1 | -104.06 Million USD | 7.67% |
| 2016 Q4 | 37.85 Million USD | 284.71% |
| 2016 Q3 | -20.49 Million USD | 73.73% |
| 2016 Q2 | -78.02 Million USD | 25.02% |
| 2016 FY | 37.85 Million USD | 133.58% |
| 2015 Q2 | -115.65 Million USD | -21.05% |
| 2015 Q4 | -112.71 Million USD | 12.82% |
| 2015 Q3 | -129.28 Million USD | -11.79% |
| 2015 FY | -112.71 Million USD | -15.34% |
| 2015 Q1 | -95.54 Million USD | 2.23% |
| 2014 FY | -97.72 Million USD | -11.88% |
| 2014 Q4 | -97.72 Million USD | 4.38% |
| 2014 Q3 | -102.19 Million USD | -6.4% |
| 2014 Q2 | -96.05 Million USD | 7.28% |
| 2014 Q1 | -103.59 Million USD | -18.6% |
| 2013 Q1 | -19.76 Million USD | 27.08% |
| 2013 FY | -87.35 Million USD | -222.24% |
| 2013 Q4 | -87.35 Million USD | 13.29% |
| 2013 Q3 | -100.74 Million USD | -379.11% |
| 2013 Q2 | -21.02 Million USD | -6.37% |
| 2012 Q1 | -42.58 Million USD | 13.54% |
| 2012 Q3 | -22.67 Million USD | 35.1% |
| 2012 Q4 | -27.1 Million USD | -19.56% |
| 2012 Q2 | -34.93 Million USD | 17.98% |
| 2012 FY | -27.1 Million USD | 44.97% |
| 2011 Q3 | -12.4 Million USD | -148.18% |
| 2011 Q1 | -3.83 Million USD | 39.42% |
| 2011 FY | -49.25 Million USD | -677.9% |
| 2011 Q4 | -49.25 Million USD | -296.91% |
| 2011 Q2 | -5 Million USD | -30.36% |
| 2010 Q1 | -8.5 Million USD | 41.31% |
| 2010 Q3 | -5.71 Million USD | 12.66% |
| 2010 Q4 | -6.33 Million USD | -10.86% |
| 2010 FY | -6.33 Million USD | 56.32% |
| 2010 Q2 | -6.54 Million USD | 23.13% |
| 2009 FY | -14.49 Million USD | -524.43% |
| 2009 Q4 | -14.49 Million USD | -905.11% |
| 2009 Q3 | -1.44 Million USD | 10.32% |
| 2009 Q2 | -1.6 Million USD | -2.85% |
| 2009 Q1 | -1.56 Million USD | 32.64% |
| 2008 Q4 | -2.32 Million USD | 21.51% |
| 2008 FY | -2.32 Million USD | 66.02% |
| 2008 Q1 | -5.09 Million USD | 25.5% |
| 2008 Q2 | -5.42 Million USD | -6.53% |
| 2008 Q3 | -2.95 Million USD | 45.46% |
| 2007 FY | -6.83 Million USD | 34.99% |
| 2007 Q4 | -6.83 Million USD | 15.29% |
| 2007 Q3 | -8.06 Million USD | 12.24% |
| 2007 Q2 | -9.19 Million USD | 4.62% |
| 2007 Q1 | -9.63 Million USD | 8.31% |
| 2006 Q2 | 88.81 Thousand USD | 106.88% |
| 2006 FY | -10.5 Million USD | -574.42% |
| 2006 Q4 | -10.5 Million USD | -2195.05% |
| 2006 Q3 | 501.62 Thousand USD | 464.8% |
| 2006 Q1 | -1.29 Million USD | 17.17% |
| 2005 Q4 | -1.55 Million USD | -3397.91% |
| 2005 FY | -1.55 Million USD | 22.89% |
| 2005 Q2 | -421.06 Thousand USD | 59.16% |
| 2005 Q3 | 47.25 Thousand USD | 111.22% |
| 2005 Q1 | -1.03 Million USD | 48.98% |
| 2004 Q2 | -5.1 Million USD | 24.97% |
| 2004 Q4 | -2.02 Million USD | 36.38% |
| 2004 Q3 | -3.17 Million USD | 37.82% |
| 2004 Q1 | -6.8 Million USD | -372.55% |
| 2004 FY | -2.02 Million USD | -40.27% |
| 2003 FY | -1.44 Million USD | 29.99% |
| 2003 Q2 | -1.49 Million USD | 10.44% |
| 2003 Q3 | -1.15 Million USD | 22.63% |
| 2003 Q4 | -1.44 Million USD | -24.54% |
| 2003 Q1 | -1.66 Million USD | 18.87% |
| 2002 Q1 | -2.4 Million USD | 18.55% |
| 2002 Q4 | -2.05 Million USD | -99.67% |
| 2002 Q3 | -1.03 Million USD | 41.16% |
| 2002 Q2 | -1.75 Million USD | 27.25% |
| 2002 FY | -2.05 Million USD | 30.38% |
| 2001 Q2 | -739.53 Thousand USD | -2409.6% |
| 2001 Q3 | -1.49 Million USD | -102.13% |
| 2001 Q1 | 32.02 Thousand USD | 106.85% |
| 2001 FY | -2.95 Million USD | -532.43% |
| 2001 Q4 | -2.95 Million USD | -97.74% |
| 2000 FY | -467.39 Thousand USD | 53.26% |
| 2000 Q3 | -1.51 Million USD | 49.44% |
| 2000 Q4 | -467.39 Thousand USD | 69.2% |
| 2000 Q1 | -4.06 Million USD | -306.49% |
| 2000 Q2 | -3 Million USD | 26.17% |
| 1999 Q3 | -1.7 Million USD | 29.17% |
| 1999 Q2 | -2.4 Million USD | 22.58% |
| 1999 Q1 | -3.1 Million USD | 20.51% |
| 1999 FY | -1 Million USD | 74.36% |
| 1999 Q4 | -1 Million USD | 41.18% |
| 1998 FY | -3.9 Million USD | 63.55% |
| 1998 Q2 | -6.7 Million USD | 30.21% |
| 1998 Q3 | -4.9 Million USD | 26.87% |
| 1998 Q4 | -3.9 Million USD | 20.41% |
| 1998 Q1 | -9.6 Million USD | 10.28% |
| 1997 FY | -10.7 Million USD | 0.0% |
| 1997 Q4 | -10.7 Million USD | -12.63% |
| 1997 Q3 | -9.5 Million USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Intra-Cellular Therapies, Inc. | -130.82 Million USD | -13.646% |
| PainReform Ltd. | -7.95 Million USD | -1770.212% |
| Alvotech | 1.06 Billion USD | 113.97% |
| Collegium Pharmaceutical, Inc. | 435.33 Million USD | 134.153% |
| ANI Pharmaceuticals, Inc. | 94.2 Million USD | 257.825% |
| Aquestive Therapeutics, Inc. | 74.95 Million USD | 298.375% |
| Journey Medical Corporation | -9.7 Million USD | -1431.382% |
| Dynavax Technologies Corporation | 106.63 Million USD | 239.431% |
| Esperion Therapeutics, Inc. | 458.69 Million USD | 132.414% |
| Bright Green Corporation | 1.84 Million USD | 8172.97% |
| Pacira BioSciences, Inc. | 432.74 Million USD | 134.358% |
| Embecta Corp. | 1.31 Billion USD | 111.332% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | -850.977% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | -850.977% |
| SCYNEXIS, Inc. | -19.35 Million USD | -668.382% |
| Petros Pharmaceuticals, Inc. | -5.06 Million USD | -2838.153% |
| Silver Spike Investment Corp. | -32.61 Million USD | -355.917% |
| China SXT Pharmaceuticals, Inc. | -9.42 Million USD | -1476.734% |
| Alpha Teknova, Inc. | 1.97 Million USD | 7632.008% |
| Safety Shot Inc | -2.28 Million USD | -6408.644% |
| Procaps Group, S.A. | 242.93 Million USD | 161.203% |
| Cosmos Health Inc. | 8.59 Million USD | 1830.719% |
| Theratechnologies Inc. | 24.87 Million USD | 697.812% |
| Harrow Health, Inc. | 116.41 Million USD | 227.715% |
| Sonoma Pharmaceuticals, Inc. | -2.52 Million USD | -5800.073% |
| Biofrontera Inc. | 4.05 Million USD | 3765.726% |
| DURECT Corporation | -7.65 Million USD | -1842.538% |
| Supernus Pharmaceuticals, Inc. | -33.52 Million USD | -343.469% |
| Cronos Group Inc. | -663.32 Million USD | 77.585% |
| OptiNose, Inc. | 58.06 Million USD | 356.061% |
| Ironwood Pharmaceuticals, Inc. | 623.38 Million USD | 123.851% |
| Kala Pharmaceuticals, Inc. | -14.57 Million USD | -920.326% |
| RedHill Biopharma Ltd. | -5.18 Million USD | -2766.968% |
| Organogenesis Holdings Inc. | 15.01 Million USD | 1090.354% |
| Guardion Health Sciences, Inc. | -6.35 Million USD | -2237.895% |
| Cumberland Pharmaceuticals Inc. | 106.85 Thousand USD | 139238.336% |
| Radius Health, Inc. | 359.28 Million USD | 141.383% |
| Universe Pharmaceuticals INC | 197.2 Thousand USD | 75493.027% |
| ProPhase Labs, Inc. | 19.23 Million USD | 873.136% |
| Phibro Animal Health Corporation | 454.84 Million USD | 132.688% |
| Procaps Group S.A. | 242.93 Million USD | 161.203% |
| TherapeuticsMD, Inc. | 3.67 Million USD | 4142.464% |
| Viatris Inc. | 17.13 Billion USD | 100.868% |
| Rockwell Medical, Inc. | 4.45 Million USD | 3436.666% |
| Aytu BioPharma, Inc. | -4.87 Million USD | -2948.633% |
| Tilray Brands, Inc. | 158.97 Million USD | 193.524% |
| Lifecore Biomedical, Inc. | 121.89 Million USD | 221.972% |
| Shineco, Inc. | 29.29 Million USD | 607.615% |
| PetIQ, Inc. | 351.93 Million USD | 142.247% |
| Regencell Bioscience Holdings Limited | -2.9 Million USD | -5024.436% |
| Incannex Healthcare Limited | -5.48 Million USD | -2610.699% |
| Neurocrine Biosciences, Inc. | 177.3 Million USD | 183.859% |
| Alimera Sciences, Inc. | 55.3 Million USD | 368.82% |
| Assertio Holdings, Inc. | -32.52 Million USD | -357.075% |
| Shuttle Pharmaceuticals Holdings, Inc. | -1.48 Million USD | -9887.213% |
| Clever Leaves Holdings Inc. | -4.81 Million USD | -2988.53% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | -1710.218% |
| Avadel Pharmaceuticals plc | 4.21 Million USD | 3625.773% |
| Hempacco Co., Inc. | 13.61 Million USD | 1192.07% |
| Talphera, Inc. | -5.72 Million USD | -2498.878% |
| Alvotech | 1.06 Billion USD | 113.97% |
| Eagle Pharmaceuticals, Inc. | 7.14 Million USD | 2180.921% |
| Lantheus Holdings, Inc. | -96.71 Million USD | -53.74% |
| Currenc Group, Inc. | -16.57 Million USD | -797.126% |
| Kamada Ltd. | -46.43 Million USD | -220.217% |
| Indivior PLC | -33.95 Million USD | -337.918% |
| Evoke Pharma, Inc. | 260.57 Thousand USD | 57159.352% |
| Flora Growth Corp. | -713 Thousand USD | -20752.992% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | -1710.218% |
| Evolus, Inc. | 63.7 Million USD | 333.38% |
| HUTCHMED (China) Limited | -197.45 Million USD | 24.702% |
| Amphastar Pharmaceuticals, Inc. | 479.11 Million USD | 131.033% |
| Akanda Corp. | 3.9 Million USD | 3907.555% |